The Institute of Cancer Research (ICR) has opened a new state of the art Centre for Cancer Drug Discovery at Sutton’s London Cancer Hub site.
The opening of the centre marks an important step in the development of the London Cancer Hub, a global centre for cancer research and innovation delivering real benefits for cancer patients and for the local and UK economy. Sutton Council is working closely with partners, including the ICR, the Royal Marsden NHS Foundation Trust, the Greater London Authority and Epsom and St Helier University Hospitals NHS Trust to redevelop the whole site, ensuring they have facilities of the highest quality for their crucial work.
The new, world-leading £75m centre, which covers 7,300 square metres will house the world’s first ‘Darwinian’ drug discovery programme alongside various other promising projects centred on discovering new strategies to tackle cancer.
Sutton Council is also currently re-modelling the former temporary school on the site to create the Innovation Gateway, a new, modern incubator space that will enable start up companies and other science led enterprises to collaborate with some of the top cancer researchers in the world.
The London Cancer Hub will help attract world-class researchers from across the globe to be part of London’s thriving life-science industry. It will be a game changer for UK cancer research – increasing the number of drugs that the ICR and its partners can discover, develop and commercialise and increasing the chances of transformative new cancer treatments reaching patients.
It will attract UK and international businesses, bringing high-value investment, skills and knowledge to Sutton generating a projected £13m in business rates and £1.2bn GVA to the UK economy annually. It will create 13,000 jobs and inspire and educate future scientists and clinicians, providing opportunities for the next generation of research leaders to pursue careers in science.